Provided by Tiger Trade Technology Pte. Ltd.

Fortress Biotech

2.87
+0.10003.61%
Post-market: 2.870.00000.00%19:30 EDT
Volume:202.72K
Turnover:575.76K
Market Cap:95.34M
PE:1.04
High:2.88
Open:2.80
Low:2.79
Close:2.77
52wk High:4.53
52wk Low:2.18
Shares:33.22M
Float Shares:23.22M
Volume Ratio:0.30
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.77
EPS(LYR):-0.0674
ROE:115.99%
ROA:-7.65%
PB:0.58
PE(LYR):-42.55

Loading ...

Sep 27, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Sep 25, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Sep 23, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2024

Major Issues Report

Form 8-K - Current report
Jul 25, 2024

Major Issues Report

Form 8-K - Current report
Jul 19, 2024

Major Issues Report

Form 8-K - Current report
Jul 05, 2024

Major Issues Report

Form 8-K - Current report
Jun 28, 2024

Major Issues Report

Form 8-K - Current report
Jun 28, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 25, 2024

Correspondence

Form CORRESP - Correspondence
Jun 25, 2024

Major Issues Report

Form 8-K - Current report
May 31, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 31, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 29, 2024

Correspondence

Form CORRESP - Correspondence
May 29, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]